Archives

by in
Entry Author Date Location
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News 05/12/11 Seattle
Matrix Genetics Pursues the Algae Fuel Dream in the Lab, Not With Big Steel Tanks, Giant Ponds 05/12/11 Seattle
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Washington’s Innovation Corridor a Key to Recovery 02/18/11 Seattle
Top Trends to Watch in 2011 From Experts in Infotech, Biotech, Cleantech 01/19/11 National
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News 01/06/11 Seattle
Hutch Buys Building for $36M 12/17/10 Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News 12/16/10 Seattle
Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System 12/13/10 Seattle
Hutch Snaps Up $5.6M at Holiday Gala 12/08/10 Seattle
Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry 12/08/10 San Francisco
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO 11/12/10 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
Report: Ikaria Withdraws IPO, Leaving Arch, Hutch in the Lurch 11/10/10 Seattle
Ikaria IPO Finds So-So Demand, Company Slashes Proposed Offering 38 Percent 11/10/10 Seattle
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
Steve Davis, the Techie Turned Global Healthie, Gets Dose of Reality at Close Range in India 11/05/10 Seattle
Dendreon’s Plan to Meet Demand, Arch Banks on Ikaria IPO, RF Surgical Leaves No Sponge Behind, & More Seattle-Area Life Sciences News 11/04/10 Seattle
Arch, Hutch Stand to Gain From “Hibernation on Demand” Through Ikaria IPO 11/02/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
A Nobel Laureate’s Stealthy Biotech, Its Japanese Pharma Backer, and the Englishman In Charge 10/14/10 Boston
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News 10/07/10 Seattle
Stanford, UCSD Biologists Take Plunge Into Arpanet-Style Project With Sage Bionetworks 10/06/10 Seattle
Fred Hutch Wins $14M Grant to Establish Cancer Immunotherapy Trial Center 10/04/10 Seattle
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News 09/23/10 Seattle
ZymoGenetics Will Be Missed. How Seattle Biotech Can Recover and Thrive 09/21/10 Seattle
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase 09/20/10 Seattle
The Future of Humankind Depends on Quality Science Education 09/20/10 National
Page 3 of 7 « previous page · next page »